Kybora
KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

8 10 月, 2025
News
Strategic collaboration combin…
READ MORE

KYBORA is pleased to announce that Wang Zhi has joined its team at EVP and Managing Director of its Asia Pac operations.

21 6 月, 2023
News
SHANGHAI AND PRINCET…
READ MORE

Q1 2023 Global Biopharma Market Trends and News

12 4 月, 2023
News
In this report (down…
READ MORE

KYBORA is happy to announce that Khai Meng Ang has joined its team as Senior Advisor for China.

6 2 月, 2023
News
KYBORA's mission is …
READ MORE

KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.

3 2 月, 2023
News
KYBORA is pleased to…
READ MORE
Daewoong License to CS Pharma

KYBORA is pleased to announce the licensing of Daewoong’s development stage IPF therapy (Bersiporocin) to CS Pharmaceuticals for the Greater China region.

3 2 月, 2023
News
KYBORA is pleased to…
READ MORE

KYBORA is pleased to announce that its trademarks have been approved and registered by the Chinese government.

24 6 月, 2022
News
KYBORA and its Chine…
READ MORE

KYBORA is pleased to announce the partnering of ORLADEYO® (berotralstat) in Latin America.

14 6 月, 2022
News
KYBORA is please to …
READ MORE

KYBORA is pleased to announce the licensing of Accure Therapeutics ACT-01 to Oculis.

3 3 月, 2022
Global Licensing
KYBORA is pleased to…
READ MORE
Howard Lei Joined KYBORA

KYBORA Welcomes Howard Lei To its Team

22 12 月, 2021
News
Princeton, NJ – Octo…
READ MORE
Leonid Parshenkov

KYBORA Welcomes Leonid Parshenkov To The Team

21 9 月, 2021
News
KYBORA is pleased to…
READ MORE
Startegy Presentation

BGx: Trends and Strategic Options

30 8 月, 2021
News
Download full presen…
READ MORE
Jean Chatellier, Kybora

Jean Chatellier in “Ask the Experts” Interview Series by Sejelas

2 7 月, 2021
News
Recently, KYBORA Man…
READ MORE

TYPE & ENTER: